← Leaderboards
James Michael Pierce
University Of Georgia (Uga)
$27,180,370
Attributed
$27,180,370
Total exposure
61
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6M · FY2005–18$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$53,961,325 · 63
By mechanism
P41$42,761,099 · 57
U01$5,682,827 · 1
R01$4,292,337 · 2
T32$801,703 · 1
S06$393,359 · 1
R13$30,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Georgia (Uga)
Same institution · by research overlap
- Stephen Dalton$12,703,536
- Geert-Jan Boons$26,938,877
Others in their field
Top investigators on “Biomedical Resource”
- Eric S Lander · Whitehead Institute For Biomedical Res$327,348,429
- Richard A Gibbs · Baylor College Of Medicine$197,881,494
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$159,861,320
- Ronald J Sokol · University Of Colorado Denver$154,805,139
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$154,215,387
- Joseph E Robertson · Oregon Health & Science University$128,745,682
Research focus
Biomedical ResourcePolysaccharidesFundingGlycoproteinsResearch PersonnelResourcesTechnologyGrantInstitutionSourceUnited States National Institutes Of HealthCarbohydratesCellsLectinLinkTissuesStructureEnzymesComputer Retrieval Of Information On Scientific Projects DatabaseCollaborationsProteinsGlycosylationTranscriptGenes
Grant awards (138)
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$1,905,105
P41 · FY2018 · GM · contact PI
Glycoscience Training Program$112,977
T32 · FY2018 · GM · contact PI
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$1,905,105
P41 · FY2017 · GM · contact PI
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)$1,905,105
P41 · FY2017 · GM · contact PI
Glycoscience Training Program$186,446
T32 · FY2017 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$103,236
U01 · FY2017 · CA · contact PI
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)$1,905,105
P41 · FY2016 · GM · contact PI
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$1,905,105
P41 · FY2016 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$452,180
U01 · FY2016 · CA · contact PI
Glycoscience Training Program$184,424
T32 · FY2016 · GM · contact PI
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)$1,714,596
P41 · FY2015 · GM · contact PI
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$1,714,596
P41 · FY2015 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$453,938
U01 · FY2015 · CA · contact PI
Glycoscience Training Program$182,454
T32 · FY2015 · GM · contact PI
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$1,704,118
P41 · FY2014 · GM · contact PI
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)$1,704,118
P41 · FY2014 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$441,980
U01 · FY2014 · CA · contact PI
Glycoscience Training Program$135,402
T32 · FY2014 · GM · contact PI
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)$2,859,327
P41 · FY2013 · GM · contact PI
NATIONAL CENTER FOR BIOMEDICAL GLYCOMICS$2,859,327
P41 · FY2013 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$326,634
U01 · FY2013 · CA · contact PI
Integrated Technology Resource for Biomedial Glycomics$1,686,251
P41 · FY2012 · GM · contact PI
Discovery and Development of Cancer Glycomarkers$466,670
U01 · FY2012 · CA · contact PI
Integrated Technology Resource for Biomedial Glycomics$1,292,109
P41 · FY2011 · RR · contact PI
Integrated Technology Resource for Biomedial Glycomics$431,324
P41 · FY2011 · RR · contact PI
GLYCOPROTEINS EXPRESSING POLYSIALIC ACID AS MARKERS OF LOSS OF PLURIPOTENCY$171,464
P41 · FY2011 · RR · contact PI
TECHNOLOGY DEVELOPMENT FOR ISOLATING GPI-ANCHORED GLYCOPROTEINS$34,382
P41 · FY2011 · RR · contact PI
IDENTIFICATION OF A PANCREATIC CARCINOMA-SPECIFIC N-LINKED GLYCAN EPITOPE$3,447
P41 · FY2011 · RR · contact PI
MOUSE BRAIN GLYCOPROTEINS EXPRESSING O-MAN AND ASN-LINKED GLYCANS$3,447
P41 · FY2011 · RR · contact PI
SYNTHETIC PEPTIDES FOR THE STUDY OF IN VITRO KINETICS & SPECIFICITY OF POMGNT1$3,447
P41 · FY2011 · RR · contact PI
IDENTIFICATION OF POTENTIAL GLYCAN MARKERS OF MOUSE MAMMARY CANCER STEM CELLS$3,447
P41 · FY2011 · RR · contact PI
COMPARING GLYCANS OF HER-2 MOUSE MAMMARY TUMORS TO NON-DISEASED MAMMARY TISSUE$3,447
P41 · FY2011 · RR · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$1
U01 · FY2011 · CA · contact PI
Integrated Technology Resource for Biomedial Glycomics$1,305,160
P41 · FY2010 · RR · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$864,718
U01 · FY2010 · CA · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$700,000
U01 · FY2010 · CA · contact PI
GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID$130,516
P41 · FY2010 · RR · contact PI
SYNTHETIC PEPTIDES FOR THE STUDY OF IN VITRO KINETICS & SPECIFICITY OF POMGNT1$2,610
P41 · FY2010 · RR · contact PI
MOUSE BRAIN GLYCOPROTEINS EXPRESSING O-MAN AND ASN-LINKED GLYCANS$2,610
P41 · FY2010 · RR · contact PI
Integrated Technology Resource for Biomedial Glycomics$1,267,143
P41 · FY2009 · RR · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$411,353
U01 · FY2009 · CA · contact PI
GlcNAcT-V Regulation of Cell Surface Structure/Function$362,675
R01 · FY2009 · CA · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$307,166
U01 · FY2009 · CA · contact PI
Integrated Technology Resource for Biomedial Glycomics$296,866
P41 · FY2009 · RR · contact PI
GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID$126,714
P41 · FY2009 · RR · contact PI
Translational and Clinical Research on Cancer: Glycomics Applications$30,000
R13 · FY2009 · CA · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$23,760
U01 · FY2009 · CA · contact PI
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$2,534
P41 · FY2009 · RR · contact PI
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$2,534
P41 · FY2009 · RR · contact PI
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$2,534
P41 · FY2009 · RR · contact PI
MOUSE BRAIN GLYCOPROTEINS EXPRESSING O-MAN AND ASN-LINKED GLYCANS$2,534
P41 · FY2009 · RR · contact PI
HUMAN NEUROBLASTOMA GLYCOPROTEINS EXPRESSING HNK-1 EPITOPE$2,534
P41 · FY2009 · RR · contact PI
Integrated Technology Resource for Biomedial Glycomics$1,880,240
P41 · FY2008 · RR · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$411,357
U01 · FY2008 · CA · contact PI
GlcNAcT-V Regulation of Cell Surface Structure/Function$352,110
R01 · FY2008 · CA · contact PI
GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID$188,024
P41 · FY2008 · RR · contact PI
SITE-SPECIFIC GLYCOSYLATION OF ALPHA-DYSTROGLYCAN FROM RAT BRAIN$3,760
P41 · FY2008 · RR · contact PI
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$3,760
P41 · FY2008 · RR · contact PI
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$3,760
P41 · FY2008 · RR · contact PI
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$3,760
P41 · FY2008 · RR · contact PI
HUMAN NEUROBLASTOMA GLYCOPROTEINS EXPRESSING HNK-1 EPITOPE$3,760
P41 · FY2008 · RR · contact PI
MOUSE BRAIN GLYCOPROTEINS EXPRESSING O-MAN AND ASN-LINKED GLYCANS$3,760
P41 · FY2008 · RR · contact PI
Integrated Technology Resource for Biomedical Glycomics$1,235,108
P41 · FY2007 · RR · contact PI
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers$719,834
U01 · FY2007 · CA · contact PI
GlcNAcT-V Regulation of Cell Surface Structure/Function$348,623
R01 · FY2007 · CA · contact PI
GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID$123,511
P41 · FY2007 · RR · contact PI
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$2,470
P41 · FY2007 · RR · contact PI
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$2,470
P41 · FY2007 · RR · contact PI
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$2,470
P41 · FY2007 · RR · contact PI
MOUSE BRAIN GLYCOPROTEINS EXPRESSING O-MAN AND ASN-LINKED GLYCANS$2,470
P41 · FY2007 · RR · contact PI
HUMAN NEUROBLASTOMA GLYCOPROTEINS EXPRESSING HNK-1 EPITOPE$2,470
P41 · FY2007 · RR · contact PI
N-LINKED GLYCAN STRUCTURAL CHANGES DURING DROSOPHILA EMBRYO DEVELOPMENT$2,470
P41 · FY2007 · RR · contact PI
SITE-SPECIFIC GLYCOSYLATION OF ALPHA-DYSTROGLYCAN FROM RAT BRAIN$2,470
P41 · FY2007 · RR · contact PI
Integrated Technology Resource for Biomedical Glycomics$1,235,423
P41 · FY2006 · RR · contact PI
GlcNAcT-V Regulation of Cell Surface Structure/Function$348,580
R01 · FY2006 · CA · contact PI
GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID$123,538
P41 · FY2006 · RR · contact PI
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$12,354
P41 · FY2006 · RR · contact PI
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$6,177
P41 · FY2006 · RR · contact PI
Integrated Technology Resource for Biomedical Glycomics$1,228,794
P41 · FY2005 · RR
GlcNAcT-V Regulation of Cell Surface Structure/Function$399,924
R01 · FY2005 · CA
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$122,879
P41 · FY2005 · RR
GLYCOSPHINGOLIPID BIOSYNTHESIS INHIBITORS: STEM CELL DIFFERENTIATION$61,440
P41 · FY2005 · RR
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$12,288
P41 · FY2005 · RR
CRYSTALLIZATION OF GLCNAC-T V FOR X-RAY DIFFRACTION STUDIES$12,288
P41 · FY2005 · RR
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$6,144
P41 · FY2005 · RR
MODULATION OF INTEGRIN FUNCTION BY CHANGES IN N-LINKED OLIGOSACCHARIDE BRANCHING$3,686
P41 · FY2005 · RR
NOVEL CHANGES IN HEPARAN SULFATE STRUCTURES DURING MOUSE ES CELL DIFFERENTIATION$3,686
P41 · FY2005 · RR
Integrated Technology Resource for Biomedical Glycomics$1,198,492
P41 · FY2004 · RR
GlcNAc TV Regulation of Cell Surface Structure/Function$238,509
R01 · FY2004 · CA
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$119,849
P41 · FY2004 · RR
GLYCOSPHINGOLIPID BIOSYNTHESIS INHIBITORS: STEM CELL DIFFERENTIATION$59,925
P41 · FY2004 · RR
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V &SCREENING FOR INHIBITORS$41,910
P41 · FY2004 · RR
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$29,934
P41 · FY2004 · RR
DNA ARRAY ANALYSIS OF STEM CELL DIFFERENTIATION I$19,176
P41 · FY2004 · RR
IDENTIFICATION OF GLCNAC T V ACTIVE SITE$17,958
P41 · FY2004 · RR
DNA ARRAY ANALYSIS OF STEM CELL DIFFERENTIATION II$11,985
P41 · FY2004 · RR
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL AND PANETH CELLS$11,985
P41 · FY2004 · RR
CRYSTALLIZATION OF GLCNAC-T V FOR X-RAY DIFFRACTION STUDIES$11,985
P41 · FY2004 · RR
VALIDATION OF PREDICTED STRUCTURE OF GLCNAC-T V AND SCREENING FOR INHIBITORS$5,992
P41 · FY2004 · RR
ANALYSIS OF HEPARAN EXPRESSION IN EMBRYONIC STEM CELLS$3,595
P41 · FY2004 · RR
MODULATION OF INTEGRIN FUNCTION BY CHANGES IN N-LINKED OLIGOSACCHARIDE BRANCHING$3,595
P41 · FY2004 · RR
CRYSTALLIZATION OF XENOPUS OOCYTE LECTIN$600
P41 · FY2004 · RR
MODULATION OF INTEGRIN FUNCTION BY CHANGES IN N-LINKED OLIGOSACCHARIDE BRANCHING$600
P41 · FY2004 · RR
CRYSTALLIZATION OF GLCNAC T V FOR XRAY DIFFRACTION STUDIES$600
P41 · FY2004 · RR
INVESTIGATION OF HUMAN LECTIN FUNCTION IN ENDOTHELIAL &PANETH CELLS$600
P41 · FY2004 · RR
Integrated Technology Resource for Biomedical Glycomics$1,730,689
P41 · FY2003 · RR
GlcNAc TV Regulation of Cell Surface Structure/Function$523,629
R01 · FY2003 · CA
GlcNAc TV Regulation of Cell Surface Structure/Function$519,149
R01 · FY2002 · CA
ENZYMATIC SYNTH OF N ACETYLLACTOSAMINE OLIGOMERS FOR GALECTIN 1 INTERACTION$288,015
P41 · FY2002 · RR
DELETION OF GLCNAC T V MRNA IN MOUSE EMBRYOGENESIS$288,015
P41 · FY2002 · RR
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$288,015
P41 · FY2002 · RR
EXPRESSION OF XENOPUS LECTINS DURING EMBRYO DEVELOPMENT$288,015
P41 · FY2002 · RR
LOCALIZATION OF HUMAN LECTIN EXPRESSION$288,015
P41 · FY2002 · RR
CRYSTALLIZATION OF GLCNAC T V FOR XRAY DIFFRACTION STUDIES$288,015
P41 · FY2002 · RR
IDENTIFICATION OF GLCNAC T V ACTIVE SITE$288,015
P41 · FY2002 · RR
Structural basis for GnT-V therapeutic inhibitors$253,400
R01 · FY2002 · CA
NOVEL ENDOTHELIAL LECTINS--FUNCTION AND REGULATION$238,779
R01 · FY2002 · GM
CLONING AND CHARACTERIZATION OF CYTOSOLIC PROTEIN TYROSINE KINASE$109,973
S06 · FY2002 · GM
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$288,015
P41 · FY2001 · RR
ENZYMATIC SYNTH OF N ACETYLLACTOSAMINE OLIGOMERS FOR GALECTIN 1 INTERACTION$288,015
P41 · FY2001 · RR
DELETION OF GLCNAC T V MRNA IN MOUSE EMBRYOGENESIS$288,015
P41 · FY2001 · RR
EXPRESSION OF XENOPUS LECTINS DURING EMBRYO DEVELOPMENT$288,015
P41 · FY2001 · RR
LOCALIZATION OF HUMAN LECTIN EXPRESSION$288,015
P41 · FY2001 · RR
CRYSTALLIZATION OF GLCNAC T V FOR XRAY DIFFRACTION STUDIES$288,015
P41 · FY2001 · RR
IDENTIFICATION OF GLCNAC T V ACTIVE SITE$288,015
P41 · FY2001 · RR
GlcNAc TV Regulation of Cell Surface Structure/Function$249,591
R01 · FY2001 · CA
NOVEL ENDOTHELIAL LECTINS--FUNCTION AND REGULATION$231,983
R01 · FY2001 · GM
CLONING AND CHARACTERIZATION OF CYTOSOLIC PROTEIN TYROSINE KINASE$109,973
S06 · FY2001 · GM
NOVEL ENDOTHELIAL LECTINS--FUNCTION AND REGULATION$225,385
R01 · FY2000 · GM
CLONING AND CHARACTERIZATION OF CYTOSOLIC PROTEIN TYROSINE KINASE$109,973
S06 · FY2000 · GM
ENZYMATIC SYNTH OF N ACETYLLACTOSAMINE OLIGOMERS FOR GALECTIN 1 INTERACTION$109,918
P41 · FY2000 · RR
EXPRESSION OF XENOPUS LECTINS DURING EMBRYO DEVELOPMENT$97,705
P41 · FY2000 · RR
BREAST CARCINOMA GLYCOPROTEIN CHANGES CAUSED BY ONCOGENE EXPRESSION$85,492
P41 · FY2000 · RR
CLONING AND CHARACTERIZATION OF CYTOSOLIC PROTEIN TYROSINE KINASE$63,440
S06 · FY2000 · GM
IDENTIFICATION OF GLCNAC T V ACTIVE SITE$12,213
P41 · FY2000 · RR
LOCALIZATION OF HUMAN LECTIN EXPRESSION$0
P41 · FY2000 · RR
DELETION OF GLCNAC T V MRNA IN MOUSE EMBRYOGENESIS$0
P41 · FY2000 · RR
CRYSTALLIZATION OF GLCNAC T V FOR XRAY DIFFRACTION STUDIES$0
P41 · FY2000 · RR